Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: Insights into specificity and potency

Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: Insights into specificity and potency Total synthesis of the-potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology Epoxomicin, a potent and selective proteasome inhibitor, exhibits<i>in vivo</i>antiinflammatory activity Genetic Basis for the Biosynthesis of the Pharmaceutically Important Class of Epoxyketone Proteasome Inhibitors The Carmaphycins: New Proteasome Inhibitors Exhibiting an α,β‐Epoxyketone Warhead from a Marine Cyanobacterium Mode of Action of Epoxyphomalins A and B and Characterization of Related Metabolites from the Marine-Derived Fungus <i>Paraconiothyrium</i> sp. Macyranones: Structure, Biosynthesis, and Binding Mode of an Unprecedented Epoxyketone that Targets the 20S Proteasome Epoxomicin, a new antitumor agent of microbial origin. Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome Inhibitors